Leaderboard

En | De
Sie sind hier: Hämatologie » Neoplasie 01. April 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Anämie
Gerinnungsstörungen
Neoplasie
Anderes
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8344  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 166868  
   
LY-H as a potential screening biomarker for lymphocyte activation in peripheral blood.
Front Immunol
Qin KC, Yang CH, Zhang YH, Wang XY, Jin PP, Ding N.
PMID: 41918755 [PubMed - indexed for MEDLINE]


A 64-Year-Old Man Presenting With Diplopia and Right Orbital Swelling Due to Mucosa-Associated Lymphoid Tissue Lymphoma.
Am J Case Rep
Altamimi LM, Algahtani FH, Alharbi MG, Alakeel FS, Alhentti BA.
PMID: 41918141 [PubMed - indexed for MEDLINE]


Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center study.
Radiat Oncol
Stolz SM, von Wachter C, Willmann J, Rieger MJ, Kreutmair S, Mamozai W, Rösler W, Hockl P, Ahmadsei M, Christ SM, Motisi L, Guckenberger M, Schneidawind D, Mayinger M.
PMID: 41917971 [PubMed - as supplied by publisher]


Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan.
Int J Hematol
Yamaguchi K, Aoki M, Osako R.
PMID: 41917309 [PubMed - as supplied by publisher]


EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N.
PMID: 41916363 [PubMed - in process]


HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41916353 [PubMed - in process]


Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia.
Blood Adv
Furman RR, Wierda WG, Patten PE, Chaves JM, Brown JR, Munir T, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos JC, Patel K, Woyach JA, de Borja M, Wang MH, Jain N, O'Brien SM MD, Byrd JC.
PMID: 41915892 [PubMed - as supplied by publisher]


Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.
Blood
Gower N, Feugier P, Westin JR, Schiano de Colella JS, Tilly H, Palomba ML, Julia E, Damaj GL, Durand A, Flinn IW, Lemonnier F, Morineau N, Ysebaert L, Bartlett N, Thieblemont C, Ribrag V, Gastinne T, Arthur D, Fouillet L, Guidez S, Houot R, da Silva MG, Barnes J, Bijou F, Cartron G, Martin Garcia-Sancho AM, Eradat HA, Cheminant M, López-Guillermo AL, Abrisqueta P, Abraham J, Sarkozy C, Izutsu K, Crochet G, Sehn LH, Gkasiamis A, Yge ML, Chartier L, Fowler NH, Xerri L, Salles GA, Morschhauser F.
PMID: 41915772 [PubMed - as supplied by publisher]


Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial.
Cancer Immunol Immunother
Ghasabeh AS, Izadpanah A, Bakhtiyaridovvombaygi M, Seresht-Ahmadi M, Parkhideh S, Seraji HR, Sabri A, Yazdanparast S, Hajifathali A, Gharehbaghian A, Roshandel E.
PMID: 41915180 [PubMed - indexed for MEDLINE]


Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study.
Int J Hematol
Ogasawara F, Minami Y, Chi S, Ueda T, Fukushima K, Kojima K.
PMID: 41915141 [PubMed - as supplied by publisher]


Relationships Between Clinician-Patient Communication and the Quality of Life of Patients With Leukaemia: A Prospective Cross-Sectional Global Study.
Cancer Control
Nier S, Poots AJ, Gunn S, Oliva EN, Ionova T, Salek S.
PMID: 41914705 [PubMed - indexed for MEDLINE]


Incidence and Risk Factors of Serious Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia: A CYP-C Population-Based Study.
Pediatr Blood Cancer
de Villiers N, Éthier C, Laverdière C, Alos N, Tran TH, Pelland-Marcotte MC.
PMID: 41914452 [PubMed - as supplied by publisher]


Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm.
Cancer
Perrone S, De Fazio L, Monachetti S, Molica M.
PMID: 41914434 [PubMed - indexed for MEDLINE]


Potential Application of CAR-NK Cells as an Ex Vivo Therapy for T-cell-related Diseases.
Front Biosci (Landmark Ed)
Kwon D, Kang KS.
PMID: 41914298 [PubMed - indexed for MEDLINE]


Navigating the Landscape of Antibody Drug Conjugates: Current Trends and Future Research Prospects in Acute Myeloid Leukemia.
Front Biosci (Elite Ed)
Shah AC, Saluja SG, Trivedi JD, Mehta SH, Patel R, Chorawala MR, Dudhat K, Prajapati BG.
PMID: 41914165 [PubMed - indexed for MEDLINE]


Exploring mixed phenotype acute leukemia: Clinical, immunophenotypic, cytogenetic, and prognostic insights from a tertiary care center.
Indian J Pathol Microbiol
Sarjana, Jasmita, Agarwal M, Ganesh V, Mahapatra M.
PMID: 41913419 [PubMed - indexed for MEDLINE]


Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study.
Oncologist
Lokhorst DN, van den Bemt BJF, Smit Y, Hermens RPMG, Blijlevens NMA, Bekker CL.
PMID: 41913063 [PubMed - as supplied by publisher]


HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41911849 [PubMed - in process]


HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 41911838 [PubMed - in process]


HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J.
PMID: 41911756 [PubMed - in process]


   
   Artikel 1 - 20 / 166868    Seite 1 von 8344  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1